These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11114264)

  • 1. Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease--a stereological approach.
    Banerjee C; Nyengaard JR; Wevers A; de Vos RA; Jansen Steur EN; Lindstrom J; Pilz K; Nowacki S; Bloch W; Schröder H
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):666-72. PubMed ID: 11114264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
    Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
    Gotti C; Moretti M; Bohr I; Ziabreva I; Vailati S; Longhi R; Riganti L; Gaimarri A; McKeith IG; Perry RH; Aarsland D; Larsen JP; Sher E; Beattie R; Clementi F; Court JA
    Neurobiol Dis; 2006 Aug; 23(2):481-9. PubMed ID: 16759874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
    J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.
    Shepherd CE; Thiel E; McCann H; Halliday GM
    Neurobiol Dis; 2001 Feb; 8(1):136-46. PubMed ID: 11162247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes.
    Teaktong T; Graham A; Court J; Perry R; Jaros E; Johnson M; Hall R; Perry E
    Glia; 2003 Jan; 41(2):207-11. PubMed ID: 12509811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases.
    Kawamata J; Shimohama S
    J Alzheimers Dis; 2011; 24 Suppl 2():95-109. PubMed ID: 21403387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.
    Chan-Palay V; Asan E
    J Comp Neurol; 1989 Sep; 287(3):373-92. PubMed ID: 2570794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
    Qi XL; Nordberg A; Xiu J; Guan ZZ
    Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy.
    Maloteaux JM; Laterre EC; Laduron PM; Javoy-Agid F; Agid Y
    Mov Disord; 1988; 3(3):255-62. PubMed ID: 3193963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of hnRNP B1 in the postmortem temporal cortices of patients with Alzheimer's disease.
    Ishikawa M; Mizukami K; Iwakiri M; Kamma H; Ikonomovic MD; Dekosky ST; Asada T
    Neurosci Res; 2004 Dec; 50(4):481-4. PubMed ID: 15567486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia.
    Heffernan JM; Eastwood SL; Nagy Z; Sanders MW; McDonald B; Harrison PJ
    Exp Neurol; 1998 Apr; 150(2):235-9. PubMed ID: 9527892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders.
    Whitehouse PJ; Kellar KJ
    J Neural Transm Suppl; 1987; 24():175-82. PubMed ID: 2960781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
    Hof PR; Cox K; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.